Literature DB >> 22438237

Pregnancy-induced analgesia: a combined psychophysical and neurophysiological study.

G Draisci1, S Catarci, C Vollono, B A Zanfini, C Pazzaglia, C Cadeddu, D Virdis, M Valeriani.   

Abstract

BACKGROUND: To investigate changes in heat pain threshold and modifications in heat pain processing during pregnancy and labour, seventy-six nulliparous pregnant women were enrolled in two studies.
METHODS: In the first study (psychophysical), 60 pregnant women underwent a quantitative sensory testing (QST) investigating heat perception in two body areas (right forearm and T10 dermatome) according to these groups: 32-33 gestational weeks (GW), 39-40 GW, early stage of active labour and 24 h after the delivery. In the other study (neurophysiological), contact heat-evoked potentials (CHEPs) were recorded in other 16 women at the 32nd GW and in 11 of these also at the 40th GW.
RESULTS: The psychophysical study showed that heat pain threshold was significantly increased at the forearm at 32-33 GW (median ± IQR: 39.6 ± 0.7 °C), at 39-40 GW (40.6 ± 1.1 °C) and at early stage of active labour (40.8 ± 1.5 °C) as compared to 20 non-pregnant controls (p < 0.001). Heat pain threshold tested at T10 level was significantly increased at 32-33 GW (41.0 ± 1.6 °C), at 39-40 GW (42.1 ± 1.8 °C), and at early stage of active labour (42.3 ± 1.3 °C) as compared to the non-pregnant women (p < 0.001). The N2-P2 CHEP amplitude (main negative N2 and positive P2 components of the vertex biphasic potential) recorded from the pregnant women was significantly lower at the 40th than at the 32nd GW, after stimulation of both the forearm (p < 0.001) and the abdomen (p < 0.001).
CONCLUSIONS: In pregnant women, there is a progressive increase of heat pain threshold and a reduction of the CHEP amplitude, suggesting that a general inhibitory mechanism may be involved.
© 2012 European Federation of International Association for the Study of Pain Chapters.

Entities:  

Mesh:

Year:  2012        PMID: 22438237     DOI: 10.1002/j.1532-2149.2012.00139.x

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  6 in total

1.  The Programmed Cell Death Ligand-1/Programmed Cell Death-1 Pathway Mediates Pregnancy-Induced Analgesia via Regulating Spinal Inflammatory Cytokines.

Authors:  HuiLing Tan; ZhenDong Ding; ChengLiang Zhang; JianQin Yan; Yong Yang; Ping Li
Journal:  Anesth Analg       Date:  2021-11-01       Impact factor: 6.627

2.  Pregnancy suppresses neuropathic pain induced by chronic constriction injury in rats through the inhibition of TNF-α.

Authors:  Yoshiko Onodera; Megumi Kanao-Kanda; Hirotsugu Kanda; Tomoki Sasakawa; Hiroshi Iwasaki; Takayuki Kunisawa
Journal:  J Pain Res       Date:  2017-03-08       Impact factor: 3.133

3.  Pilot study on patients with Mal de Debarquement syndrome during pregnancy.

Authors:  Viviana Mucci; Josephine M Canceri; Yves Jacquemyn; Angelique Van Ombergen; Leen K Maes; Paul H Van de Heyning; Cherylea J Browne
Journal:  Future Sci OA       Date:  2019-02-21

4.  Pre-operative pain sensitivity: A prediction of post-operative outcome in the obstetric population.

Authors:  Luana Mifsud Buhagiar; Olivia A Cassar; Mark P Brincat; George G Buttigieg; Anthony Serracino Inglott; Maurice Zarb Adami; Lilian M Azzopardi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10

5.  17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice.

Authors:  Valentina Vacca; Sara Marinelli; Luisa Pieroni; Andrea Urbani; Siro Luvisetto; Flaminia Pavone
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

6.  "Luteal Analgesia": Progesterone Dissociates Pain Intensity and Unpleasantness by Influencing Emotion Regulation Networks.

Authors:  Katy Vincent; Charlotte J Stagg; Catherine E Warnaby; Jane Moore; Stephen Kennedy; Irene Tracey
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-23       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.